Top compounds associated with response to INO80D


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.1 0.001
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.13 0.002
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA vincristine CTRPv2 pan-cancer AAC 0.1 0.002
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.11 0.002
mRNA RITA CTRPv2 pan-cancer AAC 0.12 0.002
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV